PMV Pharmaceuticals Statistics
Total Valuation
PMVP has a market cap or net worth of $83.05 million. The enterprise value is -$103.43 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PMVP has 51.75 million shares outstanding. The number of shares has increased by 10.47% in one year.
Current Share Class | 51.75M |
Shares Outstanding | 51.75M |
Shares Change (YoY) | +10.47% |
Shares Change (QoQ) | +0.19% |
Owned by Insiders (%) | 2.14% |
Owned by Institutions (%) | 57.46% |
Float | 40.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.41 |
P/TBV Ratio | 0.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.98, with a Debt / Equity ratio of 0.07.
Current Ratio | 13.98 |
Quick Ratio | 13.48 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.63% and return on invested capital (ROIC) is -21.29%.
Return on Equity (ROE) | -23.63% |
Return on Assets (ROA) | -20.27% |
Return on Capital (ROIC) | -21.29% |
Revenue Per Employee | n/a |
Profits Per Employee | -$816,905 |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -16.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.20% in the last 52 weeks. The beta is 1.48, so PMVP's price volatility has been higher than the market average.
Beta (5Y) | 1.48 |
52-Week Price Change | -37.20% |
50-Day Moving Average | 1.57 |
200-Day Moving Average | 1.67 |
Relative Strength Index (RSI) | 44.49 |
Average Volume (20 Days) | 174,995 |
Short Selling Information
The latest short interest is 847,180, so 1.64% of the outstanding shares have been sold short.
Short Interest | 847,180 |
Short Previous Month | 975,907 |
Short % of Shares Out | 1.64% |
Short % of Float | 2.07% |
Short Ratio (days to cover) | 4.16 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -78.59M |
Pretax Income | -65.05M |
Net Income | -51.47M |
EBITDA | -77.12M |
EBIT | -78.59M |
Earnings Per Share (EPS) | -$1.00 |
Full Income Statement Balance Sheet
The company has $182.84 million in cash and $13.27 million in debt, giving a net cash position of $184.67 million or $3.57 per share.
Cash & Cash Equivalents | 182.84M |
Total Debt | 13.27M |
Net Cash | 184.67M |
Net Cash Per Share | $3.57 |
Equity (Book Value) | 197.91M |
Book Value Per Share | 3.82 |
Working Capital | 176.06M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$46.71 million and capital expenditures -$796,000, giving a free cash flow of -$47.50 million.
Operating Cash Flow | -46.71M |
Capital Expenditures | -796,000 |
Free Cash Flow | -47.50M |
FCF Per Share | -$0.92 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |